PHARMACEUTICAL FOR BONE MARROW STEM CELL TRANSPLANTATION THERAPY

摘要

A pharmaceutical comprising as an active ingredient CTACK (T-cell attracting chemokine) that is effective in the regenerative therapy utilizing bone marrow stem cells, especially the regenerative therapy of skin diseases utilizing transplanted bone marrow stem cells. In particular, the pharmaceutical provides a novel therapeutic method for congenital skin diseases whose fundamental treatment has been regarded as being difficult, for example, congenital epidermolysis bullosa.